313 completed, 138 unknown, 33 recruiting, 27 terminated. 580 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 580 | Completed 313, Unknown 138, Recruiting 33, Terminated 27, Not yet recruiting 26, Withdrawn 19, Active not recruiting 16, Enrolling by invitation 6, Suspended 2 |
Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans Integrated care - Opioid Use Disorder, HIV | Not applicable | Not yet recruiting | VA Office of Research and Development | 60 | 2028-04-03 | 2026-04-24 |
| STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD) | Not applicable | Not yet recruiting | University of Miami | 200 | 2027-05-01 | 2026-11-12 |
| ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) - Hepatitis C | Not applicable | Not yet recruiting | Johns Hopkins University | 200 | 2026-11-01 | 2025-11-10 |
| Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 388 | 2026-11-01 | 2026-10-29 |
| Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 1660 | 2026-11-01 | 2026-10-29 |
| HIV/HBV/HCV Triple Screening in Primary Care electronic medical record alert linked to orders - HIV, HBV (Hepatitis B Virus) | Not applicable | Recruiting | University of Texas Southwestern Medical Center | 50 | 2026-11-01 | 2026-10-29 |
| Strengthening, Guidance, Health, Empowerment Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 200 | 2026-09-01 | 2026-08-26 |
| Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs Partner navigation intervention booster session - HEPATITIS C (HCV), Opioid Use Disorder | Not applicable | Not yet recruiting | University of California, San Francisco | 50 | 2026-09-01 | 2026-06-08 |
| Developing an HIV Disclosure Intervention for Men in Uganda HIV disclosure intervention - HIV Infections, Sexually Transmitted Infections (Not HIV or Hepatitis) | Not applicable | Not yet recruiting | Brigham and Women's Hospital | 70 | 2026-09-01 | 2026-07-16 |
| Characterization of Peri-Hemorrhagic Cerebral Edema Using Synthetic Sodium Imaging With 7-Tesla and 3-Tesla MRI Sodium tissue concentration will be measured in perihematomal oedema - Intracerebral Haemorrhage, ICH | Not applicable | Not yet recruiting | University Hospital, Lille | 48 | 2026-09-01 | 2026-09-01 |
| Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B Sintilimab, Pegylated Interferon-α 2b, Nucleos(t)ide Analogues - Chronic Hepatitis B | Not applicable | Not yet recruiting | Beijing 302 Hospital | 60 | 2026-09-01 | 2026-09-09 |
| "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission" HBsAg RDT Women, Treatment by TDF if HBcrAg RDT positive, Treatment by TDF - HBV Infection, Pregnancy | Not applicable | Recruiting | ANRS, Emerging Infectious Diseases | 3200 | 2026-08-10 | 2026-10-08 |
| Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3) Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID) - HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV) | Not applicable | Not yet recruiting | University of Georgia | 50 | 2026-08-01 | 2025-12-18 |
| Integrating Hepatitis B Elimination Into the HIV Program in Zambia Integrated HBV/HIV Service Delivery Model - Hepatitis B, HIV | Not applicable | Enrolling by invitation | Centre for Infectious Disease Research in Zambia | 460 | 2026-07-21 | 2026-10-15 |
| Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing PPP-CCM - HEPATITIS C (HCV) | Not applicable | Recruiting | University of Washington | 444 | 2026-06-01 | 2026-11-12 |
| A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test TruPlex HIV/HepB/Syphilis Rapid Test - HIV1 Infection, HIV 2 Infection | Not applicable | Recruiting | bioLytical Laboratories | 500 | 2026-05-14 | 2026-11-04 |
| Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women doxy-PEP, Serial STI testing, HIV PEP/PrEP - Sexually Transmitted Infections (Not HIV or Hepatitis), HIV Infections | Not applicable | Not yet recruiting | University of Washington | 720 | 2026-05-01 | 2026-01-28 |
| Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients Agent Intelligence education - Chronic Hepatitis B | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2000 | 2026-05-01 | 2026-04-09 |
| Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare HBVCare Mobile App - Chronic Hepatitis B | Not applicable | Recruiting | Institute of Gastroenterology and Hepatology, Vietnam | 70 | 2026-04-15 | 2026-05-15 |
| Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis Babao Dan Capsule, Babao Dan Capsule simulant - HEPATITIS B CHRONIC, Cirrhosis, Liver | Not applicable | Not yet recruiting | Nanfang Hospital, Southern Medical University | 1034 | 2026-04-01 | 2026-04-22 |
Showing 20 of 580. Sign in to see all of them.
Hepatitis C (267) · Hepatitis B (146) · Hepatitis B, Chronic (86) · Hepatitis C, Chronic (55) · HIV Infections (40) · Acquired Immunodeficiency Syndrome (32) · Fibrosis (28) · Substance-Related Disorders (26) · Hepatitis, Alcoholic (25) · Liver Cirrhosis (25) · Carcinoma, Hepatocellular (24) · Opioid-Related Disorders (19) · Liver Diseases (18) · Sexually Transmitted Diseases (18)
Digestive System Diseases (578) · Liver Diseases (562) · Infections (510) · Virus Diseases (507) · Communicable Diseases (500) · Blood-Borne Infections (499) · Hepatitis, Viral, Human (493) · RNA Virus Infections (337) · Flaviviridae Infections (304) · Pathological Conditions, Signs and Symptoms (231) · Pathologic Processes (224) · DNA Virus Infections (219) · Hepadnaviridae Infections (216) · Disease Attributes (178)
Ribavirin (23) · peginterferon alfa-2a (22) · Tenofovir (18) · entecavir (18) · Blood Specimen Collection (11) · peginterferon alfa-2b (10) · Hepatitis B Vaccines (9) · Sofosbuvir (8) · Standard of Care (8) · Lamivudine (7) · Motivational Interviewing (5) · Telemedicine (5) · daclatasvir (5) · efavirenz (5) · tenofovir alafenamide (5)
Institute of Liver and Biliary Sciences, India (15) · National Taiwan University Hospital (13) · Third Affiliated Hospital, Sun Yat-Sen University (12) · Kirby Institute (9) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Johns Hopkins University (8) · Yale University (8) · Foundation for Innovative New Diagnostics, Switzerland (7) · Hospices Civils de Lyon (7) · VA Office of Research and Development (7) · bioLytical Laboratories (7) · ANRS, Emerging Infectious Diseases (6) · US Department of Veterans Affairs (6) · University of California, Los Angeles (6) · University of California, San Francisco (6)
United States (185) · China (69) · France (40) · India (23) · Taiwan (23) · Australia (19) · Canada (16) · Spain (14) · Belgium (13) · Egypt (13) · United Kingdom (9) · Germany (8) · Israel (8) · Netherlands (8) · Thailand (8)
Liang Peng, Doctor (8) · Adeline Nyamathi, PhD (2) · Alain Litwin, MD (2) · Alain Litwin, MD, MPH (2) · Ali Ismail, lecturer (2) · Amy Silberbogen, PhD (2) · Christophe Moreno, MD, PhD (2) · David Perlman, MD (2) · Frederick L Altice, MD (2) · Geert Robaeys, prof. dr. (2) · Grace X Ma, PhD (2) · Jason Haukoos, MD, MSc (2) · Jennifer J Kiser, PharmD (2) · Jennifer Kiser, PharmD (2)
PMID 26519381, PMID 28487349, PMID 10761562, PMID 10921388, PMID 10965678, PMID 11059069, PMID 11059125, PMID 11413125, PMID 12450640, PMID 12618532, PMID 12761382, PMID 12823087, PMID 15560058, PMID 15618643, PMID 15637534, PMID 15784668, PMID 16122679, PMID 16816555, PMID 17204261, PMID 17410291, PMID 17451562, PMID 17552026, PMID 17695343, PMID 17938165, PMID 17947390, PMID 17975845, PMID 17980513, PMID 18233994, PMID 18379007, PMID 18495540, PMID 18752430, PMID 18807097, PMID 19617848, PMID 19638084, PMID 19663708, PMID 19897823, PMID 20091629, PMID 20190585, PMID 20332290, PMID 20334708, PMID 20479894, PMID 20491973, PMID 20529203, PMID 20608766, PMID 20638216, PMID 21218306, PMID 21241735, PMID 21301463, PMID 21767252, PMID 21782772
P30AI042853 (2), 1IK2CX002822-01A1 (1), 1RC1DA028415 (1), 1UL1TR001430 (1), 2008 (1), 4UH3DA044798-03 (1), 4UH3DA044829-03 (1), DP2DA053720 (1), I50HX002903 (1), K01DA059329 (1), K01TW007408 (1), K23AA023753 (1), K23DA022454 (1), K23DA039060 (1), K23DK089004 (1)